Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases"

Clin Immunol. 2021 Mar:224:108665. doi: 10.1016/j.clim.2021.108665. Epub 2021 Jan 8.
No abstract available

Keywords: Autoimmunity; Autoinflammation; COVID-19; Immune response; SARS-CoV-2; Type I interferon; mRNA vaccine.

Publication types

  • Letter
  • Comment

MeSH terms

  • Autoimmune Diseases*
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • RNA
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • RNA